Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under
article
OA: bronze
CC0
⤵ 1 in-corpus citation
AI-generated summary
This pooled analysis found that women aged 25 and under experienced similar bleeding, efficacy, and safety profiles with oral estradiol valerate/dienogest compared to older women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Women aged ≤25 and >25 years have a similar experience with an E2V/DNV oral contraceptive, supporting this as an appropriate contraceptive option in younger and older women.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest via openalex
- Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel via openalex
- Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study via openalex
- Dienogest: A New Therapeutic Agent for the Treatment of Endometriosis via openalex
- Effect of four oral contraceptives on hemostatic parameters via openalex
- Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: Results from the multicentre, randomised, double-blind, active-controlled HARMONY II study via openalex
- Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: A pooled analysis of three studies conducted in North America and Europe via openalex
- Estradiol Valerate and Dienogest: A Novel Four-Phasic Oral Contraceptive Pill Effective for Pregnancy Prevention and Treatment of Heavy Menstrual Bleeding via openalex
- Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive via openalex
- Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive via openalex
- Hormone withdrawal-associated symptoms: Comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate via openalex
- Impact of estrogen type on cardiovascular safety of combined oral contraceptives via openalex
- Metabolic and Haemostatic Effects of Estradiol Valerate/Dienogest, a Novel Oral Contraceptive via openalex
- Metabolic impact of combined hormonal contraceptives containing estradiol via openalex
- Noncontraceptive health benefits of combined oral contraception via openalex
- Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest via openalex
- Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill via openalex
- doi:10.1136/bmjsrh-2017-200036 via openalex
- doi:10.1080/13625187.2016.1241991 via openalex
- doi:10.1016/j.beem.2012.09.004 via openalex
- doi:10.1080/13625187.2018.1465546 via openalex
- doi:10.1016/j.contraception.2006.08.012 via openalex
- doi:10.2147/ijwh.s59059 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-10T10:20:16.744338+00:00
License: CC0
· commercial use OK